Product Name
Breast Cancer Susceptibility Protein 2 (BRCA2), Polyclonal Antibody
Popular Item
Full Product Name
Polyclonal Antibody to Breast Cancer Susceptibility Protein 2 (BRCA2)
Product Gene Name
anti-BRCA2 antibody
[Similar Products]
Matching Pairs
Unconjugated Antibody: Breast Cancer Susceptibility Protein 2 (MBS2027663)
Immunogen: Breast Cancer Susceptibility Protein 2 (MBS2030641)
Matching Pairs
Unconjugated Antibody: Breast Cancer Susceptibility Protein 2 (MBS2027663)
APC-CY7 Conjugated Antibody: Breast Cancer Susceptibility Protein 2 (BRCA2) (MBS2054328)
Matching Pairs
Unconjugated Antibody: Breast Cancer Susceptibility Protein 2 (MBS2027663)
PE Conjugated Antibody: Breast Cancer Susceptibility Protein 2 (BRCA2) (MBS2054329)
Matching Pairs
Unconjugated Antibody: Breast Cancer Susceptibility Protein 2 (MBS2027663)
APC Conjugated Antibody: Breast Cancer Susceptibility Protein 2 (BRCA2) (MBS2054330)
Matching Pairs
Unconjugated Antibody: Breast Cancer Susceptibility Protein 2 (MBS2027663)
Cy3 Conjugated Antibody: Breast Cancer Susceptibility Protein 2 (BRCA2) (MBS2054331)
Matching Pairs
Unconjugated Antibody: Breast Cancer Susceptibility Protein 2 (MBS2027663)
FITC Conjugated Antibody: Breast Cancer Susceptibility Protein 2 (BRCA2) (MBS2054332)
Matching Pairs
Unconjugated Antibody: Breast Cancer Susceptibility Protein 2 (MBS2027663)
HRP Conjugated Antibody: Breast Cancer Susceptibility Protein 2 (BRCA2) (MBS2054333)
Matching Pairs
Unconjugated Antibody: Breast Cancer Susceptibility Protein 2 (MBS2027663)
APC-CY7 Conjugated Secondary Antibody: Immunoglobulin G (MBS2090675)
Matching Pairs
Unconjugated Antibody: Breast Cancer Susceptibility Protein 2 (MBS2027663)
Unconjugated Secondary Antibody: Immunoglobulin G (MBS2090678)
Matching Pairs
Unconjugated Antibody: Breast Cancer Susceptibility Protein 2 (MBS2027663)
Biotin Conjugated Antibody: Breast Cancer Susceptibility Protein 2 (BRCA2) (MBS2093198)
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
MBS2027663 Technical Datasheet
Technical Datasheet PDF
3D Structure
ModBase 3D Structure for P97929
Purity/Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Form/Format
Supplied as solution form in 0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
Concentration
1mg/ml (lot specific)
Organism Species
Mus musculus (Mouse)
Source
Polyclonal antibody preparation
Immunogen
Recombinant BRCA2 (Glu2990~Ala3232) expressed in E.coli
Immunogen
Recombinant BRCA2 (Glu2990~Ala3232) expressed in E Coli.
Conjugated Antibody
The APC conjugated antibody version of this item is also available as catalog #MBS2054330
Preparation and Storage
Storage: Avoid repeated freeze/thaw cycles.
Store at 4oC for frequent use.
Aliquot and store at -20oC for 12 months.
Stability Test: The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the
expiration date under appropriate storage condition.
ISO Certification
Manufactured in an ISO 9001:2008 and ISO 13485:2003 Certified Laboratory.
Supply Chain Verification
Manufactured in a lab with traceable raw materials. Bulk orders can typically be prepared to the customera??s specifications, please inquire.
Other Notes
Small volumes of anti-BRCA2 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Applications Tested/Suitable for anti-BRCA2 antibody
WB; IHC; ICC; IP.
Application Notes for anti-BRCA2 antibody
Western blotting: 0.5-2 ug/mL;1:500-2000
Immunohistochemistry: 5-20 ug/mL;1:50-200
Immunocytochemistry: 5-20 ug/mL;1:50-200
Optimal working dilutions must be determined by end user.
Western Blot (WB) of anti-BRCA2 antibody
Western Blot: Sample: Recombinant protein.

Immunohistochemistry (IHC) of anti-BRCA2 antibody
DAB staining on fromalin fixed paraffin-embedded testis tissue)

Immunohistochemistry (IHC) of anti-BRCA2 antibody
DAB staining on IHC-P; Samples: Mouse Kidney Tissue)

NCBI/Uniprot data below describe general gene information for BRCA2. It may not necessarily be applicable to this product.
NCBI Accession #
NP_001074470.1
[Other Products]
NCBI GenBank Nucleotide #
NM_001081001.2
[Other Products]
UniProt Primary Accession #
P97929
[Other Products]
UniProt Secondary Accession #
O35922; P97383; F8VPU5[Other Products]
UniProt Related Accession #
P97929[Other Products]
NCBI Official Full Name
breast cancer type 2 susceptibility protein homolog
NCBI Official Synonym Full Names
breast cancer 2, early onset
NCBI Official Symbol
Brca2??[Similar Products]
NCBI Official Synonym Symbols
Fancd1; RAB163
??[Similar Products]
NCBI Protein Information
breast cancer type 2 susceptibility protein homolog
UniProt Protein Name
Breast cancer type 2 susceptibility protein homolog
UniProt Synonym Protein Names
Fanconi anemia group D1 protein homolog
Protein Family
Breast cancer type 2 susceptibility protein
UniProt Gene Name
Brca2??[Similar Products]
UniProt Synonym Gene Names
Fancd1??[Similar Products]
UniProt Comments for BRCA2
BRCA2: involved in double-strand break repair and/or homologous recombination. May participate in S phase checkpoint activation. Interacts with RAD51 and DSS1. Interacts with ubiquitinated FANCD2. Interacts with PALB2, enables the recombinational repair and checkpoint functions. Interacts with WDR16. Defects in BRCA2 are a cause of genetic susceptibility to breast cancer and may underlie susceptibility to uveal melanoma.
Protein type: DNA repair, damage; Nuclear receptor co-regulator; Tumor suppressor
Chromosomal Location of Human Ortholog: 5 G3|5 89.52 cM
Cellular Component: BRCA2-MAGE-D1 complex; centrosome; cytoplasm; cytoskeleton; cytosol; lateral element; nuclear chromosome, telomeric region; nucleoplasm; nucleus; protein complex; secretory granule
Molecular Function: DNA binding; gamma-tubulin binding; H3 histone acetyltransferase activity; H4 histone acetyltransferase activity; identical protein binding; protease binding; protein binding; protein C-terminus binding; single-stranded DNA binding
Biological Process: brain development; cell aging; cell cycle; cell proliferation; cellular response to DNA damage stimulus; centrosome duplication; chordate embryonic development; chromosome organization and biogenesis; cytokinesis; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; DNA damage response, signal transduction resulting in induction of apoptosis; DNA recombination; DNA repair; double-strand break repair; double-strand break repair via homologous recombination; female gonad development; hemopoiesis; homologous chromosome orientation involved in meiotic metaphase I plate congression; inner cell mass cell proliferation; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; male meiosis I; mammary gland development; mitotic recombination-dependent replication fork processing; multicellular organism growth; negative regulation of mammary gland epithelial cell proliferation; nucleotide-excision repair; oocyte maturation; positive regulation of mitotic cell cycle; positive regulation of transcription, DNA-templated; regulation of cell proliferation; regulation of cytokinesis; regulation of transcription, DNA-templated; replication fork protection; response to gamma radiation; response to UV-C; response to X-ray; spermatogenesis; telomere maintenance via recombination
Research Articles on BRCA2
1. we generated a Brca2 knock-in mouse model lacking exons 4-7 and demonstrated that these exons are dispensable for viability as well as tumor-free survival. This study provides the first in vivo evidence of the functional significance of a minor transcript of BRCA2 that can play a major role in the survival of humans who are homozygous for a clearly pathogenic mutation.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.